Daan van Abel, PhD, has a robust academic and professional background in molecular biology and biomolecular sciences, holding a MSc from Vrije Universiteit Amsterdam and a BSc from HU University of Applied Sciences Utrecht. Daan's doctoral research at VUmc focused on transcription factor STOX1A and its implications in neurodegeneration. Daan has gained extensive experience in various medical writing roles, including positions at Kiadis Pharma, AQTIS Medical, and AQLANE Medical BV. Additionally, Daan served as Associate Editor for the Journal of Alzheimer's Disease and is currently a Medical Writer at Sanofi, specializing in clinical science and project management. Prior internships at UMC Utrecht, AMC, and NKI provided foundational research experience in cancer and molecular genetics.
This person is not in the org chart
This person is not in any teams
This person is not in any offices